Detalles de la búsqueda
1.
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
Gastroenterology
; 162(7): 1891-1910, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35227777
2.
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study.
Dermatol Ther (Heidelb)
; 13(1): 221-234, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401761
3.
Growth analysis among adolescents with moderate-to-severe atopic dermatitis receiving upadacitinib in combination with topical corticosteroids in Japan: A case study series from a phase 3, randomized, controlled trial (Rising Up).
World Allergy Organ J
; 15(9): 100678, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185549
4.
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis.
JAAD Int
; 6: 27-36, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34988493
5.
Sample size and proportion of Japanese patients in multi-regional trials.
Pharm Stat
; 9(3): 207-16, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20872621
6.
One year treatment with omalizumab is effective and well tolerated in Japanese Patients with moderate-to-severe persistent asthma.
Allergol Int
; 59(2): 167-74, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20179417
7.
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study.
Int J Chron Obstruct Pulmon Dis
; 11: 2543-2551, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27785010
8.
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE.
Respir Investig
; 54(6): 428-435, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27886854
Resultados
1 -
8
de 8
1
Próxima >
>>